Skip to main content

Table 2 Characteristics of study population in the included comparative studies

From: Improvement of composite kidney outcomes by AKI care bundles: a systematic review and meta-analysis

No.

References

Age (mean)

Male (%)

Ethnicity (Caucasian%)

Type of surgery

Diabetes (%)

eGFR***

Risk score

1

Kolhe et al. [24]

76.9

44.4

91.4

NA

Unknown

NA

Charlson’s score (score ≤ 2 in 68% patients)

2

Kolhe et al. [28]

76.4

48.9

90.3

Included both surgical and medical patients

Unknown

NA

NA

3

Meersch et al. [18]

68.4

68.1

Unknown

Cardiac surgery

25.4

NA

SOFA score: (control) 6.0 ± 2.2; (intervention) 5.9 ± 2.1

APACHE score: (control) 8.9 ± 3.9; (intervention) 8.5 ± 3.2

EuroSCORE: (control) 5; (intervention) 6

4

Göcze et al. [17]

63

73.3

Unknown

Major elective non-cardiac surgery

Unknown

 > 15

SAPS II, median (IQR): (standard care) 32 (24.5–38); (intervention) 31 (22–38)

5

Kapoor et al. [11]

55.5

39

Unknown*

On-pump coronary artery bypass graft surgery

13

 > 15

EuroSCORE: (control) 3.21 ± 0.97; (GDT) 3.11 ± 0.79

6

Schanz et al. [19]

66.4

44.4

Unknown

NA

18.5

Not undergoing renal replacement therapy

SOFA score, median (IQR): (control) 5 (3–10); (intervention) 7.5 (4.5–8.3)

APACHE II score, median (IQR): (control) 15 (12–20.5); (intervention) 18 (10.25–24.5)

SAPS II, median (IQR): (control) 39 (29–45); (intervention) 36.5 (26.5–61.0)

7

Engelman et al. [26]

66.3

75.5

93.4**

Cardiac surgery

38.9

Creatinine < 2.0 mg/dL

NA

8

Koeze et al. [23]

59.6

62

Unknown

Included both surgical and medical patients

15

Creatinine < 2.0 mg/dL

APACHE IV score,  mean ± SD: (control) 51 (25); (intervention) 52.3 (25)

9

Zarbock et al. [20]

66.9

69.1

Unknown

Cardiac surgery with cardiopulmonary bypass

25.7

 > 20

SOFA score,  mean ± SD: (control) 9.6 (3.4); (intervention) 10.2 (3.1)

APACHE score, median (IQR): (control) 20 (12.5, 22); (intervention) 20 (17.5, 23)

10

Halmy et al. [27]

64

59

Unknown

Major surgery

20

 > 15

SAPS II, median (IQR): (historical control) 30 (23–38.5); (protocol implementation) 30 (24.25–37.75)

11

Couturier et al. [25]

66

71

Unknown

Cardiac surgery

26

 > 30

SOFA score: (control) 6.9 ± 2.5; (TIMP2*IGFBP7) 5.9 ± 2.1

EuroSCORE: (control) 2.4 ± 3.2; (TIMP-2·IGFBP7) 2.3 ± 2.9

12

Bourdeaux et al. [22]

63

32.2

98.7

Included both surgical and medical patients

Unknown

Not undergoing renal replacement therapy

APACHE II/EuroScore:

General ICU

(control) 15.3 ± 7.1; (intervention) 15 ± 6.6

Cardiac ICU

(control) 5.3 ± 2.9; (intervention) 8.9 ± 8.2

13

Kotwal et al. [21]

74

56

Unknown

NA

31

Not undergoing renal replacement therapy

NA

  1. APACHE Acute Physiology And Chronic Health Evaluation; CKD Chronic kidney disease; GDT Goal-directed therapy; ICU Intensive care unit; IQR Interquartile range; NA Not applicable; SAPS Simplified Acute Physiology Score; SD Standard deviation; SOFA Sequential Organ Failure Assessment
  2. *The study was conducted in a tertiary care hospital located at New Delhi, Delhi, India
  3. **Total number of Caucasian patients in the urinary biomarker/acute kidney response team
  4. ***Patients with more advanced CKD were excluded from the studies